Healthcare Marketing

//Healthcare Marketing
All Articles
June 6, 2019

Five Issues in Washington for Pharma to Watch

At the Coalition’s Rising Leaders conference on healthcare policy in Washington, D.C. May 22, a diverse set of speakers provided updates and predictions, and discussed the potential impact of the many significant healthcare policy decisions pending on Capitol Hill. This POV provides an overview of five issues to watch that were highlighted at the conference, as well as strategies for addressing them.

Read More
May 16, 2019

New List Price Mandate for DTC Television Advertising

On May 8, 2019, the Trump administration announced that the Centers for Medicare & Medicaid Services (CMS) would require drugs covered by Medicare or Medicaid to include a list price in any DTC television commercial within 60 days of the announcement, if their list price is at least $35 for a month’s supply or a course of treatment. The ruling is virtually the same as the one proposed in October 2018, and only products that advertise on TV are affected directly by the ruling. This POV provides a brief summary of the background to this ruling, a summary of its specifics, some reactions to it, and our recommendations to clients in its wake.

Read More
February 4, 2019

Rx: Authenticity, PRN

TL;DR: Authenticity is a popular 21st-century marketing buzzword. But when you pick apart what’s really behind that, you find new opportunities for pharma marketers. Authenticity, transparency, humanity, vulnerability – there are a lot of ways to describe what the public increasingly wants from brands. But simply put: they want

Read More
Load More Posts